Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Only 5% to 10% of breast cancers are caused by inherited gene mutations like BRCA1 or BRCA2. I do not carry one. But my ...

Ikebana's seasonal adaptability reflects the fluctuating experiences of cancer patients, emphasizing resilience and ...

Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, ...

The U.S. Food and Drug Administration (FDA) has approved Armlupeg (pegfilgrastim-unne) 6 milligrams per 0.6 milliliter (mg/mL ...

Kimberly Alexander spoke with CURE about how overlooked symptoms affected her husband Elijah’s path to a multiple myeloma ...

A thoracic medical oncologist and Complex Therapeutics Section Head at Memorial Sloan Kettering Cancer Center in New York. Cell therapies, which have made waves in the treatment of blood cancer, are ...

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...

Stage 1 ET is manageable with early intervention, lifestyle changes, and treatments like low-dose aspirin and cytoreductive therapy to reduce clotting risk. Meta: Stage 1 essential thrombocythemia is ...

Smoking cessation in advanced-stage cancer patients can extend life by about one year, highlighting its importance in cancer ...

Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...

A diagnosis of triple-negative breast cancer is typically made after a biopsy confirms the tumor’s receptor status. Imaging ...